Valuation: Virbac SA

Market Cap 2.78B 3.25B 2.6B 2.38B 4.47B 311B 4.53B 30.75B 11.99B 156B 12.19B 11.93B 516B P/E 2026 *
16.3x
P/E 2027 * 14.7x
Enterprise Value 2.91B 3.4B 2.72B 2.49B 4.67B 325B 4.74B 32.15B 12.54B 163B 12.75B 12.47B 540B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.73x
Free-Float
49.03%
Yield 2026 *
0.52%
Yield 2027 * 0.61%
Manager TitleAgeSince
Chief Executive Officer 46 31/08/2025
Chief Executive Officer 50 26/09/2024
Chief Operating Officer 64 31/12/2021
Director TitleAgeSince
Chairman 61 31/03/2006
Director/Board Member 68 27/07/2010
Director/Board Member 65 04/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 3.25B
+3.61%+5.34%-50.37%-57.25% 32.12B
+1.74%+1.27%+33.84%+106.46% 11.98B
-1.39%+2.78%-19.37%+5.60% 3.89B
+0.61%-0.15%-2.64%+24.81% 3.25B
-2.69%-6.50%+40.71%+35.88% 2.05B
-0.85%-1.41%+7.83%+18.06% 1.95B
+3.24%+5.70%+11.89%+140.69% 1.47B
-3.71%-6.91%-23.02%+3.23% 1.21B
-2.04%+1.98%-12.97%-41.35% 1.02B
Average -0.16%+0.12%-1.57%+26.24% 6.55B
Weighted average by Cap. +2.11%+2.97%-20.73%-3.12%

Financials

2026 *2027 *
Net sales 1.55B 1.81B 1.45B 1.33B 2.49B 173B 2.53B 17.15B 6.69B 87.02B 6.8B 6.65B 288B 1.65B 1.92B 1.54B 1.41B 2.65B 184B 2.68B 18.21B 7.1B 92.43B 7.22B 7.06B 306B
Net income 171M 200M 160M 147M 275M 19.11B 279M 1.89B 738M 9.6B 750M 734M 31.76B 190M 221M 177M 162M 305M 21.17B 309M 2.1B 817M 10.64B 831M 813M 35.18B
Net Debt 127M 148M 119M 109M 204M 14.16B 206M 1.4B 546M 7.11B 556M 544M 23.52B 75.16M 87.74M 70.32M 64.37M 121M 8.39B 122M 831M 324M 4.22B 329M 322M 13.95B
Logo Virbac SA
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
332.00EUR
Average target price
411.88EUR
Spread / Average Target
+24.06%

Quarterly revenue - Rate of surprise